Translating scientific findings into therapy is often a major hurdle. A European consortium is performing pre-clinical studies in primates to assess the efficacy of new drugs.
Chronic inflammatory conditions and degenerative disorders are attractive targets for the development of various therapeutic drugs. Along the drug research and development pipeline, and prior to clinical testing, these drugs are usually screened in animal models.
Further details: Primate models for testing drug efficacy